Clinical Characteristics and Implications of Indocyanine Green Lymphography-Identified Contralateral Inguinal Pathway of Lower-Limb Lymphedema

1Consultant in Rehabilitation Medicine, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia

2Rehabilitation Specialist, Mount Wilga Private Hospital, Hornsby, New South Wales, Australia

3Postdoctoral Research Fellow, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia

4Program Director/Senior Lecturer, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia

5Senior Lymphoedema Therapist, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia

6Research Co-ordinator, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia

7Senior Lymphoedema Therapist, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia

8Professor, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia

9Radiation Oncologist, Icon Cancer Centre, Sydney, New South Wales, Australia

10Associate Professor/Research Lead, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia

Correspondence: Helen Mackie, MBBS, FAFRM, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Level 1, 75 Talavera Rd, Macquarie University, Sydney, NSW 2109, Australia ([email protected]).

Presented in part at Australasian Lymphology Association Scientific Virtual Conference, 2020.

Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal's Web site (www.rehabonc.com).

All authors declare that they have no conflicts of interest relevant to the content of this research and manuscript.

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Online Publication date: October 19, 2022

Comments (0)

No login
gif